The evolution of infrahissian conduction time in myotonic dystrophy patients: Clinical implications

Heart

Volumn 98, Issue 4, 2012, Pages 291-296

  Lallemand, Bénédicte ^a   Clementy, Nicolas ^a   Bernard Brunet, Anne ^a   Pierre, Bertrand ^a   Corcia, Philippe ^a   Fauchier, Laurent ^a   Raynaud, Martine ^a   Pellieux, Sybille ^a   Babuty, Dominique ^a  

^a UNIVERSITÉ DE TOURS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE;

ADULT; AGED; ARTICLE; ATRIOVENTRICULAR BLOCK; CONTROLLED STUDY; DAYTIME SOMNOLENCE; DISEASE SEVERITY; ELECTROCARDIOGRAM; EPWORTH SLEEPINESS SCALE; FEMALE; FOLLOW UP; FUNCTIONAL STATUS; HEART CONDUCTION; HEART ELECTROPHYSIOLOGY; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RIGHT VENTRICLE EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MYOTONIC DYSTROPHY; NERVOUS SYSTEM FUNCTION; PATIENT MONITORING; POSITIVE END EXPIRATORY PRESSURE; PREDICTIVE VALUE; PRIORITY JOURNAL; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SLEEP APNEA SYNDROME;

ADULT; AGED; ARRHYTHMIAS, CARDIAC; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART CONDUCTION SYSTEM; HEART RATE; HUMANS; MALE; MIDDLE AGED; MYOTONIC DYSTROPHY; PREDICTIVE VALUE OF TESTS; YOUNG ADULT;

EID: 84856218926     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2011-300143     Document Type: Article

References (27)

1. Emery AE. Population frequencies of inherited neuromuscular diseasesda world survey. Neuromuscul Disord 1991;1:19-29.
2. Harley HG, Rundle SA, Reardon W, et al. Unstable DNA sequence in myotonic dystrophy. Lancet 1992;339:1125-8.
3. Phillips MF, Harper PS. Cardiac disease in myotonic dystrophy. Cardiovasc Res 1997;33:13-22. (Pubitemid 27019094)
4. de Die-Smulders CE, Howeler CJ, Thijs C, et al. Age and causes of death in adultonset myotonic dystrophy. Brain 1998;121:1557-63. (Pubitemid 28349907)
5. Groh WJ, Groh MR, Saha C, et al. Electrocardiographic abnormalities and sudden death in myotonic dystrophy type 1. N Engl J Med 2008;358:2688-97. (Pubitemid 351860861)
6. Mladenovic J, Pekmezovic T, Todorovic S, et al. Survival and mortality of myotonic dystrophy type 1 (Steinert's disease) in the population of Belgrade. Eur J Neurol 2006;13:451-4. (Pubitemid 43823357)
7. Nishioka SA, Martinelli Filho M, Marie S, et al. Myotonic dystrophy and heart disease: behavior of arrhythmic events and conduction disturbances. Arq Bras Cardiol 2005;84:330-6. (Pubitemid 40695342)
8. Mathieu J, Allard P, Potvin L, et al. A 10-year study of mortality in a cohort of patients with myotonic dystrophy. Neurology 1999;52:1658-62. (Pubitemid 29220644)
9. Reardon W, Newcombe R, Fenton I, et al. The natural history of congenital myotonic dystrophy: mortality and long-term clinical aspects. Arch Dis Child 1993;68:177-81. (Pubitemid 23066997)
10. Sabovic M, Medica I, Logar N, et al. Relation of CTG expansion and clinical variables to electrocardiogram conduction abnormalities and sudden death in patients with myotonic dystrophy. Neuromuscul Disord 2003;13:822-6. (Pubitemid 37532732)
11. Breton R, Mathieu J. Usefulness of clinical and electrocardiographic data for predicting adverse cardiac events in patients with myotonic dystrophy. Can J Cardiol 2009;25:e23-7.
12. Lazarus A, Varin J, Babuty D, et al. Long-term follow-up of arrhythmias in patients with myotonic dystrophy treated by pacing: a multicenter diagnostic pacemaker study. J Am Coll Cardiol 2002;40:1645-52. (Pubitemid 35253643)
13. Laurent V, Pellieux S, Corcia P, et al. Mortality in myotonic dystrophy patients in the area of prophylactic pacing devices. Int J Cardiol 2011;150:54-8.
14. Prystowsky EN, Prichett EL, Roses AD, et al. The natural history of conduction system disease in myotonic muscular dystrophy as determined by serial electrophysiologic studies. Circulation 1979;60:1360-4. (Pubitemid 10215883)
15. Babuty D, Fauchier L, Tena-Carbi D, et al. Is it possible to identify infrahissian cardiac conduction abnormalities in myotonic dystrophy by non-invasive methods? Heart 1999;82:634-7. (Pubitemid 29515464)
16. Babuty D, Fauchier L, Tena-Carbi D, et al. Significance of late ventricular potentials in myotonic dystrophy. Am J Cardiol 1999;84:1099-101. (Pubitemid 29505387)
17. Brooke MH. A Clinical's View of Neuromuscular Diseases, 1st edn. Baltimore: William & Wilkins, 1997:277.
18. Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991;14:540-5.
19. Ikeda N, Nademanee K, Kannan R, et al. Electrophysiologic effects of amiodarone: experimental and clinical observations relative to serum and tissue concentrations. Am Heart J 1984;108:890-8. (Pubitemid 14015515)
20. Nguyen HH, Wolfe JT, Holmes DR, et al. Pathology of the cardiac conduction system in myotonic dystrophy: a study of 12 cases. J Am Coll Cardiol 1988;11:662-71. (Pubitemid 18060228)
21. Olofsson BO, Forsberg H, Andersson S, et al. Electrocardiographic findings in myotonic dystrophy. Br Heart J 1988;59:47-52. (Pubitemid 18021566)
22. Saba S, Vanderbrink BA, Luciano B, et al. Localization of the sites of conduction abnormalities in a mouse model of myotonic dystrophy. J Cardiovasc Electrophysiol 1999;10:1214-20. (Pubitemid 29451681)
23. Groh WJ, Lowe MR, Zipes D. Severity of cardiac conduction involvement and arrhythmias in myotonic dystrophy type 1 correlates with age and CTG repeat length. J Cardiovasc Electrophysiol 2002;13:444-8. (Pubitemid 34494263)
24. Tapscott SJ, Thornton CA. Biomedecine. Reconstructing myotonic dystrophy. Science 2001;293:816-17.
25. Mörner S, Lindqvist P, Mellberg C, et al. Profound cardiac conduction delay predicts mortality in myotonic dystrophy type 1. Int J Med 2010;268:59-65.
26. Epstein AE. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices). J Am Coll Cardiol 2008;51:1-62.
27. Rautaharju PM, Surawicz B, Gettes LS. AHA/ACCF/HRS recommendations for the standardization and interpretation of ECG. Part IV: the ST segment, T and U waves, a QT interval. J Am Coll Cardiol 2009;53:982-91.